Professor Anthony Maraveyas
| Post Nominals | PhD FRCP |
|---|---|
| Biography | I graduated from Athens Medical School in 1983 and completed internal medicine training in 1990. In 1995 I was awarded my PhD from the University of London on monoclonal antibodies in Head and Neck Cancer. I completed my cancer specialty training as a lecturer at St George's hospital studying the immunology of melanoma cell vaccine therapeutics. I was appointed as a Senior Lecturer at the University of Hull in 1999 part of the founding team of Hull York Medical School, where I became professor of Cancer Medicine in 2012. I am also a honorary consultant in the Hull University Teaching Hospitals NHS Trust (HUTH) having also been the Director of R&D till 2021. I treat and am involved in clinical trials in pancreaticobiliary, kidney cancer and melanoma and have particular clinical and basic science research interest in cancer associated thrombosis (CAT). I have been national and international chief investigator for a number of studies in CAT and have worked on international guideline bodies for this condition. I have published widely in CAT with particular focus on the thromboprophylaxis of the ambulatory cancer patient and the management of incidental pulmonary embolism in cancer patients. |
| Scopus Author ID | 6701792215 |
| PhD Supervision Availability | Yes |
| PhD Topics | Currently 4 PhD students: Matthew Morfitt Farzana Haque Shirin Hasan Saeed Alqarni Recently awarded: Sophie Featherby NIHR ACF PhD studentship subject to successful application: Adenike Adebayo |